| Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect Acting Parasympathomimetic (promotes release of ACh from post-ganglionic nerve terminal endings to stimulate muscarnic receptors)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect Acting Parasympathomimetic(promotes release of ACh from post-ganglionic nerve terminal endings to stimulate muscarnic receptors) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic Antagonist (uncharged)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic Antagonist (uncharged)
 |  | 
        |  | 
        
        | Term 
 
        | Homatropine Methylbromide |  | Definition 
 
        | Muscarinic Antagonist (charged-quaternary ammonium)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic Antagonist (uncharged)
 |  | 
        |  | 
        
        | Term 
 
        | Scopalamine Methylbromide |  | Definition 
 
        | Muscarinic Antagonist (charged-quaternary ammonium)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic Antagonist (uncharged)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic Antagonist (charged-quaternary ammonium)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic Antagonist (charged-quaternary ammonium)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic Antagonist (uncharged-tertiary amine)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic Antagonist (uncharged-tertiary amine)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic Antagonist (uncharged-tertiary amine)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha, Beta-1,2,3 Agonist |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Dopamine>Beta-1>Alpha Agonist |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha-2 Agonist (inhibits release of NE)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha Antagonist (irreversible)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha-2 Antagonist (promotes release of NE)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha Antagonist (Nonselective)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta-1 Agonist (at large doses alpha and beta-2 agonist activity is seen)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta Antagonist (nonselective)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta Antagonist (nonselective)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta Antagonist (nonselective)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta Antagonist (nonselective)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta-1 Antagonist (also has Beta-2 & Alpha-1 Antagonist activity)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Reversible AChE Inhibitor (charged)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Reversible AChE Inhibitor (uncharged)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Reversible AChE Inhibitor (charged)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Reversible AChE Inhibitor (charged)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Reversible AChE Inhibitor (charged)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Reversible AChE Inhibitor (uncharged)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Reversible AChE Inhibitor (uncharged)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Reversible AChE Inhibitor (uncharged)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Reversible AChE Inhibitor (short-acting,used diagnostically-Tensilon Test)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Irreversible AChE Inhibitor (insecticide)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Irreversible AChE Inhibitor (nerve gas)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Irreversible AChE Inhibitor (nerve gas)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Irreversible AChE Inhibitor (nerve gas)
 |  | 
        |  | 
        
        | Term 
 
        | Diisopropyl Fluorophosphate (DFP) |  | Definition 
 
        | Irreversible AChE Inhibitor (long-acting)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Irreversible AChE Inhibitor (long-acting)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Irreversible AChE Inhibitor (insecticide)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic Neuron Blocker (charged)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic Neuron Blocker (uncharged)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic Neuron Blocker (irreversibly destroys adrenergic nerves)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic Neuron Blocker |  | 
        |  | 
        
        | Term 
 
        | Alpha methyl-p-tyrosine (Metyrosine) |  | Definition 
 
        | Adrenergic Neuron Blocker (inhibit tyrosine hydroxylase)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic Neuron Blocker |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Depolarizing Neuromuscular Blocker (also causes histamine release and vagal stimulation)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Depolarizing Neuromuscular Blocker |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-depolarizing Neuromuscular Blocker (also causes ganglionic blockade and histamine release)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-depolarizing Neuromuscular Blocker(also causes ganglionic blockade and histamine release) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-depolarizing Neuromuscular Blocker |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-depolarizing Neuromuscular Blocker(also causes ganglionic blockade and histamine release) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-depolarizing Neuromuscular Blocker |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-depolarizing Neuromuscular Blocker (also causes sympathetic stimulation)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-depolarizing Neuromuscular Blocker |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-depolarizing Neuromuscular Blocker |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect Acting Sympathomimetic (MAO Inhibitor)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mixed Acting Sympathomimetic (taken into adrenergic nerve, then promotes NE release)
 Also has alpha and beta agonism
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect Acting Sympathomimetic (promote NE release from adrenergic nerves after being taken up into the adrenergic nerve)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect Acting Sympathomimetic (catecholamine reuptake inhibitor)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect Acting Sympathomimetic (catecholamine reuptake inhibitor)
 |  | 
        |  | 
        
        | Term 
 
        | Tricyclic Antidepressants |  | Definition 
 
        | Indirect Acting Sympathomimetic (catecholamine reuptake inhibitor)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha Antagonist (nonselective)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Natural - Partial Alpha Agonist Synthetic - Alpha Antagonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Alpha-methyl-norepinephrine |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscle relaxant with Alpha-2 Agonist properties |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta-1&2 Antagonist Alpha-1 Antagonist
 |  | 
        |  |